CSL and biotechs warn against vaccine IP waiver
MELBOURNE: Australian biotechs including blood plasma giant CSL have warned a proposed waiver to intellectual
MELBOURNE: Australian biotechs including blood plasma giant CSL have warned a proposed waiver to intellectual